294 related articles for article (PubMed ID: 8566973)
1. AIDS in Africans living in London.
O'Farrell N; Lau R; Yoganathan K; Bradbeer CS; Griffin GE; Pozniak AL
Genitourin Med; 1995 Dec; 71(6):358-62. PubMed ID: 8566973
[TBL] [Abstract][Full Text] [Related]
2. AIDS defining conditions in Africans resident in the United Kingdom.
Del Amo J; Goh BT; Forster GE
Int J STD AIDS; 1996; 7(1):44-7. PubMed ID: 8652711
[TBL] [Abstract][Full Text] [Related]
3. AIDS defining diseases in the UK: the impact of PCP prophylaxis and twelve years of change.
Porter K; Fairley CK; Wall PG; Evans BG; Goldberg DJ; Weerasuriya M; Noone A
Int J STD AIDS; 1996 Jul; 7(4):252-7. PubMed ID: 8876355
[TBL] [Abstract][Full Text] [Related]
4. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
[TBL] [Abstract][Full Text] [Related]
5. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of tuberculosis associated with HIV infection in Taiwan.
Hsieh SM; Hung CC; Chen MY; Chang SC; Hsueh PR; Luh KT; Chuang CY
J Formos Med Assoc; 1996 Dec; 95(12):923-8. PubMed ID: 9000809
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
8. Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.
Hillman RJ; Beck EJ; Mandalia S; Satterthwaite H; Rogers PA; Forster GE; Goh BT
Genitourin Med; 1997 Feb; 73(1):44-8. PubMed ID: 9155555
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of disease in Africans with AIDS in London.
Del Amo J; Petruckevitch A; Phillips AN; Johnson AM; Stephenson JM; Desmond N; Hanscheid T; Low N; Newell A; Obasi A; Paine K; Pym A; Theodore CM; De Cock KM
AIDS; 1996 Nov; 10(13):1563-9. PubMed ID: 8931793
[TBL] [Abstract][Full Text] [Related]
10. Use of therapeutic and prophylactic drugs for AIDS by homosexual and bisexual men in three US cities.
Holmberg SD; Conley LJ; Buchbinder SP; Judson FN; Bush TJ; Katz MH; Penley KA; Hershow RC
AIDS; 1993 May; 7(5):699-704. PubMed ID: 8318177
[TBL] [Abstract][Full Text] [Related]
11. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
[TBL] [Abstract][Full Text] [Related]
12. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
[TBL] [Abstract][Full Text] [Related]
13. Disease progression and survival in HIV-1-infected Africans in London.
Del Amo J; Petruckevitch A; Phillips A; Johnson AM; Stephenson J; Desmond N; Hanscheid T; Low N; Newell A; Obasi A; Paine K; Pym A; Theodore CM; De Cock KM
AIDS; 1998 Jul; 12(10):1203-9. PubMed ID: 9677170
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
[TBL] [Abstract][Full Text] [Related]
15. HIV positive patients first presenting with an AIDS defining illness: characteristics and survival.
Poznansky MC; Coker R; Skinner C; Hill A; Bailey S; Whitaker L; Renton A; Weber J
BMJ; 1995 Jul; 311(6998):156-8. PubMed ID: 7613426
[TBL] [Abstract][Full Text] [Related]
16. Frequency and distribution patterns of opportunistic infections associated with HIV/AIDS in Uganda.
Rubaihayo J; Tumwesigye NM; Konde-Lule J; Wamani H; Nakku-Joloba E; Makumbi F
BMC Res Notes; 2016 Dec; 9(1):501. PubMed ID: 27927247
[TBL] [Abstract][Full Text] [Related]
17. The spectrum of HIV-1-related disease among outpatients in New York City.
Greenberg AE; Thomas PA; Landesman SH; Mildvan D; Seidlin M; Friedland GH; Holzman R; Starrett B; Braun J; Bryan EL
AIDS; 1992 Aug; 6(8):849-59. PubMed ID: 1418782
[TBL] [Abstract][Full Text] [Related]
18. HIV infection/acquired immunodeficiency syndrome at Siriraj Hospital, 2002: time for secondary prevention.
Anekthananon T; Ratanasuwan W; Techasathit W; Rongrungruang Y; Suwanagool S
J Med Assoc Thai; 2004 Feb; 87(2):173-9. PubMed ID: 15061301
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
Easterbrook PJ; Keruly JC; Creagh-Kirk T; Richman DD; Chaisson RE; Moore RD
JAMA; 1991 Nov; 266(19):2713-8. PubMed ID: 1942423
[TBL] [Abstract][Full Text] [Related]
20. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
